s6y
Company name or ticker
Search
Clover Biopharmaceuticals, Ltd.
D/A
Exempt (Private) Offering
Filed
Tuesday, May 24, 2022
Accession number
0001104659-22-064094
Documents
Exempt (Private) Offering
D/A
On sec.gov
Filing index
All files
Complete submission text
SGML header